You Searched For "Hetero Labs" and got 16 results
Sort By:
3 mins read
These are the companies that are making Remdesivir in India
Dr Reddy’s Lab is the sixth pharmaceutical company to introduce Remdesiv…
1 min read
Russia signs partnership with Hetero to produce Sputnik V Covid vaccine in India
Moscow, Nov 27 (IANS) The Russian Direct Investment Fund (RDIF) and Hetero, one of India's generic …
1 min read
Generic COVID-19 drug priced at ₹5,400 per vial by Hyderabad-based Hetero
They will be made available in two equal lots of 10,000 each. One lot will be immediately supp…
2 mins read
COVID-19: Hetero, Cipla get nod to manufacture, market antiviral drug remdesivir
This comes a day after the Drug Controller General of India (DCGI), considering the emergency and u…
PTI
2 mins read
These are the companies that are making Remdesivir in India
Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…
3 mins read
₹10,000 invested in Biocon just before lockdown is now worth over ₹16,500— here’s why
Indian pharmaceutical giant Biocon Limited on July 11 got approved from the Drugs Controller Genera…
2 mins read
Cipla to sell anti-viral drug remdesivir as Cipremi in India
In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…
4 mins read
Cipla, Zydus Cadila, Jubilant Life and Dr Reddy’s shares gain after FDA approves Remdesivir for treating COVID-19 patients
The shares of pharma major Cipla, Zydus Cadila, Jubilant Life Sciences and Dr Reddy Labs gained dur…
3 mins read
Indian factory at the center of latest blood pressure medicine recall reportedly shredded documents and got warnings before carcinogens appeared in their products
"We are making important strides at understanding how these impurities form and we are continuing t…
Ellen Cranley,Ellen Cranley,Benjamin Goggin
5 mins read
Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study
Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…
3 mins read
Chemcon Speciality Chemicals ₹318 crore IPO fully subscribed within two hours — Here’s what works and what doesn't
In its IPO, the public offer consists of a fresh issue of ₹165 crore and an offer for sale of 45…
4 mins read
Laxmi Organic kicks off its ₹600 crore IPO – should you subscribe?
Laxmi Organic has kicked off its initial public offer (IPO) worth ₹600 crore today, March 15. It …
2 mins read
Cipla says COVID-19 drug Remdesivir will hit market this week
As India faces a shortage of Covid-19 drug Remdesivir, the pharmaceutical company Cipla said it wil…
3 mins read
Indoco Remedies launches 400mg tablets of Favipiravir in India
Indoco Remedies, on September 26, launched its own version of generic Favipiravir under the brand n…
2 mins read
US secures almost entire world stock of Covid-19 drug remdesivir from Gilead Sciences for the next three months
As a result of an agreement with the drug maker announced earlier this week, the US Department …
7 mins read
An IBM chief explains how the tech giant has influenced the wider business world on LGBT+ diversity
Claudia Brind-Woody: We have done a lot over several years that have influenced a lot of other corp…